More news on this day
France is entering the 2026 mosquito season under an unusual chikungunya alert, after a record number of locally acquired cases in 2025 across southern regions prompted renewed travel cautions and intensified surveillance efforts.
Get the latest news straight to your inbox!
Record local transmission reshapes 2026 risk landscape
Publicly available surveillance data show that mainland France recorded an unprecedented level of local chikungunya transmission in 2025, transforming what had long been considered a mainly imported infection into a growing domestic concern. National surveillance coordinated by Santé publique France documented hundreds of autochthonous cases clustered in dozens of communes, a sharp increase compared with previous years when only sporadic local events were identified.
Reports indicate that the bulk of locally acquired infections in 2025 occurred in regions already known for the presence of the invasive tiger mosquito Aedes albopictus, including Provence Alpes Côte d’Azur, Occitanie, Auvergne Rhône Alpes and Corsica. Additional clusters were reported for the first time in regions such as Nouvelle Aquitaine and Grand Est, illustrating how the ecological range of the mosquito and associated arboviruses has moved beyond the Mediterranean corridor.
Analyses published by European and French public health agencies underline that these 2025 figures represent the highest burden of locally acquired chikungunya documented in mainland France to date. The early start of some transmission events, combined with large multi week clusters in coastal departments, has led experts to frame the 2026 season as a year of heightened vigilance rather than a return to earlier, lower baseline levels.
While chikungunya activity typically peaks between late spring and early autumn, seasonal bulletins emphasize that 2025 saw transmission extend through much of the surveillance window from May to November. This extended period of risk is a key driver of the updated messages now being disseminated to residents and travelers planning trips to the south of France in 2026.
Southern regions at the center of 2026 travel warnings
Travel oriented advisories for 2026 consistently highlight southern France as the main area of concern for chikungunya, mirroring the geographic pattern of the 2025 clusters. Departments in Provence Alpes Côte d’Azur, particularly along the Mediterranean coast in the Var, Alpes Maritimes and Bouches du Rhône, recorded some of the largest groups of locally acquired cases, with individual communes reporting several dozen infections across the summer months.
In neighboring Occitanie, localized transmission was also observed in 2025, contributing to a broader band of risk stretching from the Spanish border across Languedoc and into the lower Rhône valley. Surveillance summaries note that these southern regions combine established populations of Aedes albopictus with substantial tourist flows during the warm months, a combination that increases the likelihood that imported infections can seed local outbreaks.
Further north and inland, smaller clusters in Auvergne Rhône Alpes and first time detection of autochthonous infections in regions such as Nouvelle Aquitaine demonstrate that chikungunya is no longer confined to a single coastal strip. Nonetheless, current travel messaging still places the greatest emphasis on the Mediterranean departments, where climatic conditions and mosquito densities are considered most favorable for sustained transmission during summer 2026.
International monitoring from the European Centre for Disease Prevention and Control points out that the chikungunya situation in mainland France is occurring against a backdrop of elevated transmission in parts of the Indian Ocean and other endemic areas, generating high numbers of imported cases. These imported infections are regarded as the ignition point for local transmission in areas where the tiger mosquito is well established.
What the chikungunya alert means for travelers
The 2026 chikungunya alert for France does not involve broad movement restrictions, but it is prompting a shift in practical advice for domestic and international travelers heading to southern regions. Public health guidance disseminated through national channels urges anyone visiting colonized areas between May and November to treat mosquito avoidance as a central part of their trip planning, similar to long standing recommendations for dengue and Zika.
Information pages from French health institutions describe chikungunya as a viral disease transmitted predominately by daytime biting Aedes mosquitoes, with symptoms that commonly include sudden onset fever and intense joint pain, sometimes accompanied by headache, rash or muscle aches. Although many patients recover within days to weeks, joint symptoms can become prolonged in some individuals, and authorities classify older adults, pregnant people and those with underlying health conditions among groups that may face higher risk of complications.
Travel related advisories for 2026 emphasize straightforward protection measures: use of long clothing, insect repellents containing active ingredients endorsed by national guidance, and mosquito screens or air conditioned accommodation where available. Recommendations also stress limiting time in areas with high mosquito density at dawn and dusk, removing standing water around holiday rentals or campsites and promptly seeking medical assessment in case of fever within two weeks of a suspected mosquito exposure.
Several information campaigns launched in 2025 and carried into 2026 target both residents and visitors in affected departments, encouraging prompt reporting of suspected cases to healthcare providers and rapid local vector control when clusters are identified. Publicly available briefings indicate that the objective is not to discourage travel, but to lower the probability that imported or early local cases evolve into larger outbreaks during the peak tourist months.
Climate, vector expansion and evolving public health responses
Researchers and public health agencies are increasingly linking the expanding footprint of chikungunya risk in France to the rapid spread of Aedes albopictus combined with environmental change. Entomological maps compiled by surveillance networks show that, as of the mid 2020s, the tiger mosquito is established in the majority of mainland departments, including many that were not colonized a decade ago, with confirmed presence across much of southern and central France.
Scientific analyses cited in media and institutional reports describe how milder winters, warmer summers and changing rainfall patterns have extended the viable season for mosquito activity, particularly in low altitude Mediterranean and Atlantic zones. Modeling work on the ecological niche of Aedes albopictus suggests that suitable habitat for the vector is likely to continue spreading northwards in coming years, raising the prospect that locally acquired arboviral infections could become more common in areas that historically saw only imported cases.
In response to the record 2025 chikungunya season, French health services have maintained reinforced arbovirus surveillance for 2026, focusing on early detection of imported cases and rapid investigation of fever clusters in colonized communes. Department level bulletins describe close coordination between human health surveillance, local vector control operators and municipal authorities, with contingency plans for intensified mosquito control around confirmed cases during the May to November period.
At the European level, ECDC surveillance outputs continue to monitor both travel associated and locally acquired chikungunya cases across the EU and European Economic Area. These datasets inform regional risk assessments and support targeted communication to travelers, particularly those moving between territories experiencing active outbreaks and areas such as southern France where competent mosquito vectors are widespread.
How travelers can monitor the situation through 2026
For those planning trips to Provence, the Côte d’Azur, Corsica or other parts of southern France in 2026, publicly accessible surveillance bulletins and government health portals offer the clearest overview of current chikungunya activity. National reports are typically updated throughout the mosquito season, summarizing the number and location of imported and locally acquired cases, and highlighting departments experiencing active clusters.
European monitoring platforms complement this picture with information on transmission in popular long haul destinations, particularly the Indian Ocean and Caribbean territories that have historically been the main source of imported chikungunya infections. Travel health resources advise checking both the situation at the intended destination within France and in any countries visited shortly beforehand, especially where onward travel to the Mediterranean coast is planned.
Health agencies also encourage travelers returning from chikungunya affected regions outside Europe to remain alert to symptoms after they arrive in France or elsewhere in the EU. Early medical consultation in case of fever and joint pain helps clinicians distinguish chikungunya from dengue, COVID 19 and other febrile illnesses, and facilitates rapid public health investigation in areas where the tiger mosquito is present.
Overall, the 2026 chikungunya alert underscores how rapidly vector borne disease patterns can shift in temperate countries with established Aedes populations. For travelers, the key message is that trips to southern France remain feasible, but that robust mosquito protection and attentiveness to official health updates are now an integral part of safe travel planning during the summer and early autumn months.
Santé publique France – Chikungunya, dengue and Zika in mainland France 2024 report
Santé publique France – Chikungunya data for mainland France